Skip to content

Study on the Improvement of Upper Limb Function in Stroke Patients through Magnetic Resonance and EEG-Guided Personalized Transcranial Magnetic Stimulation Therapy

Clinical Study on the Improvement of Upper Limb Motor Function in Stroke Patients with Magnetic Resonance and EEG-Guided Personalized Repetitive Transcranial Magnetic Stimulation

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110094
Enrollment
Unknown
Registered
2025-09-30
Start date
2025-06-18
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Experimental Group:Personalized rTMS intervention
Control Group:Conventional rehabilitation therapy + Traditional rTMS

Sponsors

Second Xiangya Hospital of CSU
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with clinically and radiologically confirmed first-time unilateral stroke; 2. Aged 30-75 years, with clear upper limb motor dysfunction; 3. Able to cooperate in completing magnetic resonance imaging (MRI), electroencephalography (EEG), and rTMS treatment; 4. Have not received other brain stimulation therapies and have no severe cognitive or mental disorders; 5. No cognitive impairment, with a Mini-Mental State Examination (MMSE) score >=24; 6. Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Presence of cardiac pacemakers or other metal implants causing intolerance; 2. Severe cardiovascular, hepatic, renal dysfunction, or other systemic diseases; 3. History of neurological disorders such as Parkinson's disease or multiple sclerosis; 4. Severe mental illness affecting compliance; 5. Intolerance to magnetic stimulation; 6. Female subjects who are pregnant, breastfeeding, or test positive for pregnancy during screening.

Design outcomes

Primary

MeasureTime frame
FMA-UE;

Secondary

MeasureTime frame
Changes before and after treatment in T1, T2, Diffusion-Weighted Imaging (DWI), Diffusion Tensor Imaging (DTI), resting-state and task-based functional MRI (rs-fMRI);Serological biomarkers before and after treatment (TNF-a, IL-6, C-reactive protein, Complement C3, D-dimer, NSE);Changes in EEG cortical excitability and neural network synchronization;Barthel Index;

Countries

China

Contacts

Public ContactYing Kong

Second Xiangya Hospital of CSU

kongying1502@163.com+86 13975806768

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026